TickerFacts.

Viridian Therapeutics, Inc. (VRDN): Long-Term Debt

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$20.20M
As of 2023-12-31
+15.1%
5-year compound annual growth
2017-12-31: $10.00M2018-12-31: $10.00M2019-12-31: $7.67M2021-12-31: $02022-12-31: $4.64M2023-12-31: $20.20M$20.20M
2017-12-31 Long-Term Debt (USD) 2023-12-31
Period endedLong-Term DebtChange YoYSource filing
2023-12-31$20.20M+335.0%2024-02-27, Balance as of period end
2022-12-31$4.64Mn/a2024-02-27, Balance as of period end
2021-12-31$0n/a2023-03-09, Balance as of period end
No annual figure between 2019-12-31 and 2021-12-31.
2019-12-31$7.67M-23.3%2020-03-13, Balance as of period end
2018-12-31$10.00M0.0%2019-03-14, Balance as of period end
2017-12-31$10.00Mn/a2018-03-15, Balance as of period end